Skip to main navigation Skip to search Skip to main content

The effect of desmopressin on platelet aggregation defect in systemic amyloidosis: A preliminary report

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Systemic amyloidosis may often be complicated with haemorrhagic tendency. The causes of this manifestation are factor deficiencies, hyperfibrinolysis and vasculopathy. In order to investigate the role of platelets, if any, we performed platelet aggregation tests with different aggregants in 10 patients with systemic amyloidosis due to familial Mediterranean fever and 10 healthy controls. Platelet aggregation was defective with different aggregants (ADP, epinephrine, collagen) in patients compared with controls. Platelet aggregation tests repeated after desmopressin (DDAVP) administration were normalized. These findings may suggest a role of a platelet aggregation defect in haemorrhagic diathesis complicating systemic amyloidosis. DDAVP may benefit patients with this disease in case of bleeding and before surgical interventions.

Original languageEnglish
Pages (from-to)283-286
Number of pages4
JournalEuropean Journal of Haematology
Volume56
Issue number5
DOIs
Publication statusPublished - 1996

Keywords

  • Amyloidosis
  • Desmopressin
  • Platelet aggregation

Fingerprint

Dive into the research topics of 'The effect of desmopressin on platelet aggregation defect in systemic amyloidosis: A preliminary report'. Together they form a unique fingerprint.

Cite this